BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23023963)

  • 1. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status.
    Hegenscheid K; Schmidt CO; Seipel R; Laqua R; Ohlinger R; Kühn JP; Hosten N; Puls R
    Radiology; 2013 Jan; 266(1):72-80. PubMed ID: 23023963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal intensity of normal breast tissue at MR mammography on midfield: applying a random coefficient model evaluating the effect of doubling the contrast dose.
    Marklund M; Christensen R; Torp-Pedersen S; Thomsen C; Nolsøe CP
    Eur J Radiol; 2009 Jan; 69(1):93-101. PubMed ID: 17961948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy.
    Hegenscheid K; Schmidt CO; Seipel R; Laqua R; Ohlinger R; Hosten N; Puls R
    Eur Radiol; 2012 Dec; 22(12):2633-40. PubMed ID: 22772146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
    Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
    Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: a phase I trial.
    Boss A; Martirosian P; Gehrmann M; Artunc F; Risler T; Oesingmann N; Claussen CD; Schick F; Küper K; Schlemmer HP
    Radiology; 2007 Mar; 242(3):783-90. PubMed ID: 17209166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of hand and finger joints in patients with early rheumatoid arthritis: do we really need a full dose of gadobenate dimeglumine for assessing synovial enhancement at 3 T?
    Schueller-Weidekamm C; Lodemann KP; Grisar J; Schueller G; Weber M; Kainberger F; Platzgummer H
    Radiology; 2013 Jul; 268(1):161-9. PubMed ID: 23449952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tumor blood flow in breast tumors with T1-dynamic contrast-enhanced MR imaging: impact of dose reduction and the use of a prebolus technique on diagnostic efficacy.
    Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
    J Magn Reson Imaging; 2010 Mar; 31(3):556-61. PubMed ID: 20187197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver: segment-specific analysis of B1 field homogeneity at 3.0-T MR imaging with single-source versus dual-source parallel radiofrequency excitation.
    Pazahr S; Fischer MA; Chuck N; Luechinger R; Schick F; Nanz D; Boss A
    Radiology; 2012 Nov; 265(2):591-9. PubMed ID: 22929333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
    Millet I; Curros-Doyon F; Molinari N; Bouic-Pages E; Prat X; Alili C; Taourel P
    Radiology; 2014 Jan; 270(1):57-66. PubMed ID: 24029641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
    Müller-Schimpfle M; Ohmenhaüser K; Stoll P; Dietz K; Claussen CD
    Radiology; 1997 Apr; 203(1):145-9. PubMed ID: 9122383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.